Astrana Health (ASTH) vs ManpowerGroup (MAN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
ManpowerGroup (MAN) has outperformed Astrana Health (ASTH) over the past year, gaining 37.8% versus a gain of 22.5%. Over five years, ASTH leads with a -48.0% price change compared with -53.1% for MAN. ManpowerGroup is the larger company by market cap ($2.46 billion vs $1.84 billion), about 1.3 times the size.
On valuation, Astrana Health trades at a lower forward P/E (10.2x vs 10.9x for ManpowerGroup). ManpowerGroup pays a dividend yielding 2.72%, while Astrana Health does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASTH | MAN |
|---|---|---|
| Share price | $37.14 | $52.87 |
| Market cap | $1.84B | $2.46B |
| 1-day change | +0.38% | +1.93% |
| YTD return | +49.70% | +77.83% |
| 1-year return | +22.45% | +37.83% |
| 5-year return | -48.05% | -53.08% |
| P/E ratio (TTM) | 44.75 | 23.92 |
| Forward P/E | 10.21 | 10.90 |
| EPS (TTM) | $0.83 | $2.21 |
| Dividend yield | 0.00% | 2.72% |
| Annual dividend | $0.00 | $1.44 |
| Revenue (latest FY) | — | $17.96B |
| Revenue growth (YoY) | — | +0.58% |
| Net income (latest FY) | — | $-13.30M |
| Gross margin | — | 16.69% |
| Operating margin | — | 0.84% |
| Net margin | — | -0.07% |
| 52-week high | $51.60 | $63.88 |
| 52-week low | $18.08 | $25.15 |
| Distance from 52-week high | -28.02% | -17.24% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +39.12% | +8.44% |
| Average volume | 462.64K | 1.10M |
| Shares outstanding | 49.60M | 46.51M |
| Employees | 3,000 | 25,400 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Professional Services | Professional Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MAN has outperformed ASTH by 15.4 percentage points over the past year.
- Astrana Health trades at a higher earnings multiple (44.7x vs 23.9x trailing P/E).
- ManpowerGroup offers a meaningfully higher dividend yield (2.72% vs 0.00%).
About Astrana Health
ASTH stock →Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.
Consumer Discretionary · Professional Services · 3,000 employees
About ManpowerGroup
MAN stock →ManpowerGroup Inc. provides workforce solutions and services under the Manpower, the Experis, and the Talent Solutions brands in the Americas, Southern Europe, Northern Europe, and the Asia Pacific/the Middle East.
Consumer Discretionary · Professional Services · 25,400 employees
ASTH vs MAN FAQ
Which is bigger, Astrana Health or ManpowerGroup?
ManpowerGroup (MAN) is larger, with a market capitalization of $2.46B compared with $1.84B for Astrana Health (ASTH).
Which stock has performed better over the past year, ASTH or MAN?
MAN returned +37.83% over the past 12 months, compared with +22.45% for ASTH (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ASTH or MAN?
MAN has the lower trailing P/E at 23.9, versus 44.7 for ASTH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Astrana Health or ManpowerGroup?
ManpowerGroup pays a dividend yielding 2.72%, while Astrana Health does not currently pay a regular dividend.
Are Astrana Health and ManpowerGroup in the same industry?
Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.